Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (PVLA).
- Disclosed ownership: 7.1%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 7.1% ownership in PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (PVLA) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 3.8% | 471,202 | 0 | 471,202 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 3.8% | 471,202 | 0 | 471,202 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 2.8% | 341,883 | 0 | 341,883 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 2.8% | 341,883 | 0 | 341,883 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.4% | 53,187 | 0 | 53,187 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.4% | 53,187 | 0 | 53,187 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 6.6% | 813,085 | 0 | 813,085 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 7.1% | 879,009 | 0 | 879,009 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 7.1% | 879,009 | 0 | 879,009 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 7.1% | 879,009 | 0 | 879,009 | /s/ Mark N. Lampert | Mark N. Lampert |